​The CVDACTION Impact Model estimates the impact on health outcomes, NHS and social care demand, economic productivity and return on investment for England and every Integrated Care Board when secondary prevention treatment is optimised at scale.

 

4 high risk conditions:

• High blood pressure                   

• High cholesterol

• Diabetes                                         

• Chronic Kidney Disease

​

4 high impact treatments that are NICE recommended but substantially underused:

• Blood Pressure lowering                           

• Cholesterol lowering

• Renal Angiotensin Agents                        

• SGLT2 inhibitors

 

3 scenarios:

• Step Change is the minimum realistic near-term improvement level - using CVDACTION to find patients on suboptimal therapy and optimise treatment within routine workflows.​

• Advanced represents substantial improvement on the way to Full Uptake.

• Full Uptake is a theoretical 100% optimisation (not achievable in practice as medicines not always suitable for patients)